Economic Evaluation of Prevention Interventions for Child Sexual Exploitation or Child Sexual Abuse: A Systematic Review
Trauma, Violence, & Abuse · 2025-07 · 26 (3) · 546-559
DOI: 10.1177/15248380241284782 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Trauma, Violence, & Abuse, online erschienen am 10.10.2024. Verfasst von Sithara Wanni Arachchige Dona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Faculty of Health, Deakin University, Geelong,…. Hauptthemen laut MEDLINE: Child Abuse, Sexual, Cost-Benefit Analysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council.
Abstract (Originalsprache)
Child sexual abuse, including sexual exploitation, is a global issue, affecting 8% to 31% of girls and 3% to 17% of boys worldwide. This systematic review aims to synthesize economic evidence on the cost-effectiveness of community interventions to prevent child sexual abuse/exploitation to inform decision-making. A systematic search was conducted on eight databases for studies published until April 2023. Gray literature was searched using Google. The inclusion criteria were economic evaluation of interventions targeted at children, perpetrators/offenders, or professionals addressing child sexual abuse/exploitation. There was no limitation by country, but an English language abstract was required for non-English articles. Studies without a specific focus on child sexual abuse/exploitation, such as physical, emotional, and domestic violence-related abuse, were excluded. All costs were adjusted to US$ 2023. Reporting quality assessment was conducted using the Consolidated Health Economic Evaluation Reporting Standards 2022 checklist. Of 5,180 screened articles, 17 were included in the final synthesis, with most from the United States and focused on tertiary prevention delivered to offenders. While the intervention components varied across studies, all demonstrated promising and cost-effective results. The findings highlight a small but growing body of economic evidence for child sexual abuse/exploitation interventions. The existing economic evaluation evidence is dominated by tertiary prevention, which focuses on offenders and child victims and highlights the need for more research and action on primary and secondary preventative interventions for general and at-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Faculty of Health, Deakin University, Geelong, VIC, Australia.
- Department of Social Work, The University of Melbourne, Parkville, VIC, Australia.
- Cairns Community Legal Centre, QLD, Australia.
ORCID-Profile: Sithara Wanni Arachchige Dona, Genevieve Bloxsom
Förderung
- Australian Research Council
Zitieren
APA
Wanni Arachchige Dona, S., Bloxsom, G., Green, J., Angeles, M. R., Humphreys, C., & Gold, L. (2025). Economic Evaluation of Prevention Interventions for Child Sexual Exploitation or Child Sexual Abuse: A Systematic Review. Trauma, Violence, & Abuse, 26(3), 546-559. https://doi.org/10.1177/15248380241284782
Vancouver
Wanni Arachchige Dona S, Bloxsom G, Green J, Angeles MR, Humphreys C, Gold L. Economic Evaluation of Prevention Interventions for Child Sexual Exploitation or Child Sexual Abuse: A Systematic Review. Trauma, Violence, & Abuse. 2025;26(3):546-559. doi:10.1177/15248380241284782
BibTeX
@article{WanniArachchigeDona2025,
author = {Wanni Arachchige Dona, Sithara and Bloxsom, Genevieve and Green, Julie and Angeles, Mary Rose and Humphreys, Cathy and Gold, Lisa},
title = {Economic Evaluation of Prevention Interventions for Child Sexual Exploitation or Child Sexual Abuse: A Systematic Review},
journal = {Trauma, Violence, & Abuse},
year = {2025},
volume = {26},
number = {3},
pages = {546--559},
doi = {10.1177/15248380241284782}
}
EUVIMED